TITLE
Mepenzolate bromide effect on lung: time course

SUMMARY
Analysis of lung up to 25 hrs after a single, intratracheal administration of mepenzolate (MEP). MEP, a muscarinic receptor antagonist, decreases elastase-induced airspace enlargement. Results provide insight into molecular mechanisms underlying the beneficial effect of MEP on airspace enlargement.

ORGANISM
Mus musculus

PLATFORM
GPL6246 : [MoGene-1_0-st] Affymetrix Mouse Gene 1.0 ST Array [transcript (gene) version]

CITATIONS
Tanaka K, Ishihara T, Sugizaki T, Kobayashi D et al. Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease. Nat Commun 2013;4:2686. PMID:Â  24189798

